Synthesis, X-ray diffraction analysis, quantum chemical studies and α-amylase inhibition of probenecid derived S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids

References

• Bostrom J, Hogner A, Llinas A, et al. Oxadiazoles in medicinal chemistry. J Med Chem 2012;55:1464–30.
   Web of Science ®Google Scholar
• Pace A, Pierro P. The new era of 1,2,4-oxadiazoles. Org Biomol Chem 2009;7:4337–48.
   PubMed Web of Science ®Google Scholar
• Holla BS, Gonsalves R, Shenoy S. Synthesis and antibacterial studies of a new series of 1,2-bis(1,3, 4-oxadiazol-2-yl)ethanes and 1,2-bis(4-amino-1,2, 4-triazol-3-yl)ethanes. Eur J Med Chem 2000;35:267–71.
   PubMed Web of Science ®Google Scholar
• Jones AM, Helm JM. Emerging treatments in cystic fibrosis. Drugs 2009;69:1903–10.
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Okuma M, Yamamoto T, et al. Design and synthesis of new orally active inhibitors of human neutrophil elastase. Bioorg Med Chem 2001;9:1307–23.
   PubMed Web of Science ®Google Scholar
• Ono M, Haratake M, Saji H, Nakayama M. Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole. Bioorg Med Chem 2008;16:6867–72.
   PubMed Web of Science ®Google Scholar
• Foss FW, Jr., Mathews TP, Kharel Y, et al. Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs. Bioorg Med Chem 2009;17:6123–36.
   PubMedGoogle Scholar
• Tarasenko M, Duderin N, Sharonova T, et al. Room-temperature synthesis of pharmaceutically important carboxylic acids bearing the 1,2,4-oxadiazole moiety. Tetrahedron Lett 2017;58:3672–7.
   Web of Science ®Google Scholar
• Mohamed NA, Al-afaleq EI. Aromatic 1,3,4-oxadiazoles as thermal stabilizers for rigid poly(vinyl chloride). Polymer 1999;40:617–27.
   Web of Science ®Google Scholar
• Casu MB, Imperia P, Schulz B, Schrader S. Electronic structure at the interface between metals and new materials for organic light emitting diodes. Surf Sci 2002;507-510:666–71.
   Web of Science ®Google Scholar
• Jones RM, Leonard JN, Buzard DJ, Lehmann J. GPR119 agonists for the treatment of type 2 diabetes. Expert Opin Ther Pat 2009;19:1339–59.
   PubMed Web of Science ®Google Scholar
• Ducharme Y, Blouin M, Brideau C, et al. The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor. ACS Med Chem Lett 2010;1:170–4.
   PubMed Web of Science ®Google Scholar
• Unangst PC, Shrum GP, Connor DT, et al. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors. J Med Chem 1992;35:3691–8.
   PubMed Web of Science ®Google Scholar
• Cottrell DM, Capers J, Salem MM, et al. Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles. Bioorg Med Chem 2004;12:2815–24.
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Yamamoto T, Horiuchi T, et al. Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase. J Med Chem 2000;43:4927–9.
   PubMed Web of Science ®Google Scholar
• Hamdani SS, Khan BA, Ahmed MN, et al. Synthesis, crystal structures, computational studies and α-amylase inhibition of three novel 1,3,4-oxadiazole derivatives. J Mol Struct 2020;1200:127085.
   Web of Science ®Google Scholar
• Khan BA, Zafar S, Mughal EU, et al. Design and synthesis of novel 1,3,4-oxadiazole derivatives bearing azo moiety as biologically significant scaffolds. Lett Drug Des Discov 2018;15:1346–55.
   Web of Science ®Google Scholar
• Du Y, Zhuang J, Liu H, et al. Tuning the band gap in silicene by oxidation. ACS Nano 2014;8:10019–25.
   PubMed Web of Science ®Google Scholar
• Fish PV, Allan GA, Bailey S, et al. Potent and selective nonpeptidic inhibitors of procollagen C-proteinase. J Med Chem 2007;50:3442–56.
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Kasibhatla S, Kuemmerle J, et al. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. J Med Chem 2005;48:5215–23.
   PubMed Web of Science ®Google Scholar
• Xu J, Wei L, Mathvink RJ, et al. Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett 2006;16:5373–7.
   PubMed Web of Science ®Google Scholar
• Harfenist M, Heuser DJ, Joyner CT, et al. Selective inhibitors of monoamine oxidase. 3. Structure-activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups. J Med Chem 1996;39:1857–63.
   PubMed Web of Science ®Google Scholar
• Shen HC, Ding FX, Raghavan S, et al. Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate. J Med Chem 2010;53:2666–70.
   PubMed Web of Science ®Google Scholar
• Oliveira VS, Pimenteira C, da Silva-Alves DC, et al. The enzyme 3-hydroxykynurenine transaminase as potential target for 1,2,4-oxadiazoles with larvicide activity against the dengue vector Aedes aegypti. Bioorg Med Chem 2013;21:6996–7003.
   PubMed Web of Science ®Google Scholar
• Sangshetti JN, Chabukswar AR, Shinde DB. Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents. Bioorg Med Chem Lett 2011;21:444–8.
   PubMed Web of Science ®Google Scholar
• Ramsbeck D, Buchholz M, Koch B, et al. Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold. J Med Chem 2013;56:6613–25.
   PubMed Web of Science ®Google Scholar
• Cunningham RF, Israili ZH, Dayton PG. Clinical pharmacokinetics of probenecid. Clin Pharmacokinet 1981;6:135–51.
   PubMed Web of Science ®Google Scholar
• Mason RM. Studies on the effect of probenecid (benemid) in gout. Ann Rheum Dis 1954;13:120–30.
   PubMed Web of Science ®Google Scholar
• Mollica A, Costante R, Akdemir A, et al. Exploring new probenecid-based carbonic anhydrase inhibitors: synthesis, biological evaluation and docking studies. Bioorg Med Chem 2015;23:5311–8.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global diffusion of eHealth: making universal healthcoverage achievable: report of the third global survey on eHealth. Geneva: World Health Organization; 2017.
   Google Scholar
• World Health Organization. (2021). Diabetes.
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560–72.
   PubMed Web of Science ®Google Scholar
• Gani RS, Kudva AK, Timanagouda K, et al. Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors. Bioorg Chem 2021;114:105046.
   PubMed Web of Science ®Google Scholar
• Sipos A, Szennyes E, Hajnal NE, et al. Dual-target compounds against type 2 diabetes mellitus: proof of concept for sodium dependent glucose transporter (SGLT) and glycogen phosphorylase (GP) inhibitors. Pharmaceuticals (Basel) 2021;14:364.
   PubMedGoogle Scholar
• Siwach A, Verma PK. Therapeutic potential of oxadiazole or furadiazole containing compounds. BMC Chem 2020;14:70.
   PubMed Web of Science ®Google Scholar
• Lim KS, Cho JY, Kim BH, et al. Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers. Br J Clin Pharmacol 2009;68:883–90.
   PubMed Web of Science ®Google Scholar
• Singh P, Jangra PK. Oxadiazoles: a novel class of anti-convulsant agents. Der Chemica Sinica 2010;1:118–23.
   Google Scholar
• Husain A, Ajmal M. Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties. Acta Pharm 2009;59:223–33.
   PubMed Web of Science ®Google Scholar
• Martínez R, Zamudio GJN, Pretelin-Castillo G, et al. Synthesis and antitubercular activity of new N-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-(nitroheteroaryl)carboxamides. Heterocycl Comm 2019;25:52–9.
   Web of Science ®Google Scholar
• Arshad M, Jadoon M, Iqbal Z, et al. Synthesis, molecular structure, quantum mechanical studies and urease inhibition assay of two new isatin derived sulfonylhydrazides. J Mol Struct 2017;1133:80–9.
   Web of Science ®Google Scholar
• Sherzaman S, Sadiq-ur-Rehman , Ahmed MN, Khan BA, et al. Thiobiuret based Ni(II) and Co(III) complexes: synthesis, molecular structures and DFT studies. J Mol Struct 2017;1148:388–96.
   Web of Science ®Google Scholar
• Ahmed MN, Sadiq B, Al-Masoudi NA, et al. Synthesis, crystal structures, computational studies and antimicrobial activity of new designed bis((5-aryl-1,3,4-oxadiazol-2-yl)thio)alkanes. J Mol Struct 2018;1155:403–13.
   Web of Science ®Google Scholar
• Ahmed MN, Yasin KA, Hameed S, et al. Synthesis, structural studies and biological activities of three new 2-(pentadecylthio)-5-aryl-1,3,4-oxadiazoles. J Mol Struct 2017;1129:50–9.
   Web of Science ®Google Scholar
• Ahmed MN, Ashraf I, Yasin KA, et al. Synthesis, characterization, anti-leishmanial activity and in silico studies of 5-(4-methoxyphenyl)-2-(undecylthio)-1,3,4-oxadiazole. J Chem Soc Pak 2018;40:773–81.
   Web of Science ®Google Scholar
• Sheldrick GM. SHELXT - integrated space-group and crystal-structure determination. Acta Crystallogr A Found Adv 2015;71:3–8.
   PubMed Web of Science ®Google Scholar
• Sheldrick GM. Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem 2015;71:3–8.
   PubMed Web of Science ®Google Scholar
• Farrugia LJ. WinGX and ORTEP for Windows: an update. J Appl Crystallogr 2012;45:849–54.
   Web of Science ®Google Scholar
• Spek AL. Structure validation in chemical crystallography. Acta Crystallogr D Biol Crystallogr 2009;65:148–55.
   PubMed Web of Science ®Google Scholar
• Macrae CF, Sovago I, Cottrell SJ, et al. Mercury 4.0: from visualization to analysis, design and prediction. J Appl Crystallogr 2020;53:226–35.
   PubMed Web of Science ®Google Scholar
• Becke AD. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A Gen Phys 1988;38:3098–100.
   PubMedGoogle Scholar
• Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter 1988;37:785–9.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA. Molecular mechanical perspective on halogen bonding. J Mol Model 2012;18:4625–38.
   PubMed Web of Science ®Google Scholar
• Bader RFW. Atoms in molecules. Acc Chem Res 1985;18:9–15.
   Web of Science ®Google Scholar
• Johnson ER, Keinan S, Mori-Sanchez P, et al. Revealing noncovalent interactions. J Am Chem Soc 2010;132:6498–506.
   PubMed Web of Science ®Google Scholar
• Lu T, Chen F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem 2012;33:580–92.
   PubMed Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33–8.
   PubMed Web of Science ®Google Scholar
• Frisch J, Trucks GW, Schlegel HB, et al., Gaussian, Inc., Wallingford CT, Gaussian 09, Revision E.01. 2009.
   Google Scholar
• Spackman MA, Jayatilaka D. Hirshfeld surface analysis. CrystEngComm 2009;11:19–32.
   Web of Science ®Google Scholar
• Turner M, McKinnon J, Wolff S, et al. CrystalExplorer17. The University of Western Australia, Australia; 2017.
   Google Scholar
• Ibrahim MAA, Abdeljawaad KAA, Abdelrahman AHM, et al. Non-beta-lactam allosteric inhibitors target methicillin-resistant Staphylococcus aureus: an in silico drug discovery study. Antibiotics (Basel) 2021;10:934.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Abdelrahman AHM, Atia MAM, et al. Blue biotechnology: computational screening of sarcophyton cembranoid diterpenes for SARS-CoV-2 main protease inhibition. Mar Drugs 2021;19:391.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Abdelrahman AHM, Hegazy MF. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn 2021;39:5756–67.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Abdelrahman AHM, Mohamed TA, et al. In silico mining of terpenes from red-sea invertebrates for SARS-CoV-2 main protease (m(pro)) inhibitors. Molecules 2021;26:2082.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Badr EAA, Abdelrahman AHM, et al. In Silico targeting human multidrug transporter ABCG2 in breast cancer: database screening, molecular docking, and molecular dynamics study. Mol Inform 2022;41:e2060039.
   PubMed Web of Science ®Google Scholar
• Gilles C, Astier JP, Marchis-Mouren G, et al. Crystal structure of pig pancreatic alpha-amylase isoenzyme II, in complex with the carbohydrate inhibitor acarbose. Eur J Biochem 1996;238:561–9.
   PubMedGoogle Scholar
• Gordon JC, Myers JB, Folta T, et al. H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res 2005;33:W368–371.
   PubMed Web of Science ®Google Scholar
• OMEGA 2.5.1.4; OpenEye Scientific Software: Santa Fe, NM; 2013.
   Google Scholar
• Hawkins PC, Skillman AG, Warren GL, et al. Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inf Model 2010;50:572–84.
   PubMed Web of Science ®Google Scholar
• Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 1999;20:720–9.
   PubMed Web of Science ®Google Scholar
• SZYBKI 1.9.0.3; OpenEye Scientific Software: Santa Fe (NM); 2016.
   Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91.
   PubMed Web of Science ®Google Scholar
• Forli S, Huey R, Pique ME, et al. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 2016;11:905–19.
   PubMed Web of Science ®Google Scholar
• Mansourian M, Fassihi A, Saghaie L, et al. QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold. Med Chem Res 2015;24:394–407.
   Web of Science ®Google Scholar
• Weiner PK, Langridge R, Blaney JM, et al. Electrostatic potential molecular surfaces. Proc Natl Acad Sci U S A 1982;79:3754–8.
   PubMed Web of Science ®Google Scholar
• Anitha K, Sivakumar S, Arulraj R, et al. Synthesis, crystal structure, DFT calculations and Hirshfeld surface analysis of 3-butyl-2,6-bis-(4-fluoro-phen-yl)piperidin-4-one. Acta Crystallogr E Crystallogr Commun 2020;76:651–5.
   PubMedGoogle Scholar
• Arulraj R, Sivakumar S, Kaur M, et al. Crystal structures of three 3-chloro-3-methyl-2,6-di-aryl-piperidin-4-ones. Acta Crystallogr E Crystallogr Commun 2017;73:107–11.
   PubMed Web of Science ®Google Scholar
• McKinnon JJ, Spackman MA, Mitchell AS. Novel tools for visualizing and exploring intermolecular interactions in molecular crystals. Acta Crystallogr B 2004;60:627–68.
   PubMed Web of Science ®Google Scholar
• McKinnon JJ, Jayatilaka D, Spackman MA. Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces. ChemComm 2007;37:3814–6.
   PubMed Web of Science ®Google Scholar
• Haroon M, Akhtar T, Yousuf M, et al. Synthesis, crystal structure, Hirshfeld surface investigation and comparative DFT studies of ethyl 2-[2-(2-nitrobenzylidene)hydrazinyl]thiazole-4-carboxylate. BMC Chem 2022;16:18.
   PubMed Web of Science ®Google Scholar
• Ashfaq M, Ali A, Tahir MN, et al. Synthesis, single-crystal exploration, hirshfeld surface analysis, and DFT investigation of the thiosemicarbazones. J Mol Struct 2022;1262:133088.
   Web of Science ®Google Scholar